External validation of the FIRST trial’s simplified frailty score in a population-based cohort

Hira S. Mian; Smith Giri; Tanya M. Wildes; Amaris K. Balitsky; Arleigh McCurdy; Gregory R. Pond; Branavan Sivapathasundaram; Hsien Seow

doi:10.1038/s41375-021-01247-9

External validation of the FIRST trial’s simplified frailty score in a population-based cohort

Hira S. Mian, Smith Giri, Tanya M. Wildes, Amaris K. Balitsky, Arleigh McCurdy, Gregory R. Pond, Branavan Sivapathasundaram, Hsien Seow

Section of Medical Oncology

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	1823-1827
Number of pages	5
Journal	Leukemia
Volume	35
Issue number	6
DOIs	https://doi.org/10.1038/s41375-021-01247-9
State	Published - Jun 2021

Access to Document

10.1038/s41375-021-01247-9

Cite this

@article{87fc63588f4240ad96555adfd0b4496d,

title = "External validation of the FIRST trial{\textquoteright}s simplified frailty score in a population-based cohort",

author = "Mian, {Hira S.} and Smith Giri and Wildes, {Tanya M.} and Balitsky, {Amaris K.} and Arleigh McCurdy and Pond, {Gregory R.} and Branavan Sivapathasundaram and Hsien Seow",

note = "Funding Information: Acknowledgements HM is supported in part by the HHS Research Early Career Award from Hamilton Health Sciences Foundation. This investigation was supported by funding from Myeloma Canada. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed in the material are those of the authors, and not necessarily those of CIHI. We acknowledge Cancer Care Ontario for access to the Ontario Cancer Registry (OCR), Cancer Activity Level Reporting (ALR), Symptom Management Database (ESAS) and The New Drug Funding Program (NDFP). We thank IQVIA Solutions Canada Inc. for use of their Drug Information Database. SG is supported in part by the Walter B Frommeyer Fellowship in Investigative Medicine, Department of Medicine, University of Alabama at Birmingham",

year = "2021",

month = jun,

doi = "10.1038/s41375-021-01247-9",

language = "English",

volume = "35",

pages = "1823--1827",

journal = "Leukemia",

issn = "0887-6924",

number = "6",

}

TY - JOUR

T1 - External validation of the FIRST trial’s simplified frailty score in a population-based cohort

AU - Mian, Hira S.

AU - Giri, Smith

AU - Wildes, Tanya M.

AU - Balitsky, Amaris K.

AU - McCurdy, Arleigh

AU - Pond, Gregory R.

AU - Sivapathasundaram, Branavan

AU - Seow, Hsien

N1 - Funding Information: Acknowledgements HM is supported in part by the HHS Research Early Career Award from Hamilton Health Sciences Foundation. This investigation was supported by funding from Myeloma Canada. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed in the material are those of the authors, and not necessarily those of CIHI. We acknowledge Cancer Care Ontario for access to the Ontario Cancer Registry (OCR), Cancer Activity Level Reporting (ALR), Symptom Management Database (ESAS) and The New Drug Funding Program (NDFP). We thank IQVIA Solutions Canada Inc. for use of their Drug Information Database. SG is supported in part by the Walter B Frommeyer Fellowship in Investigative Medicine, Department of Medicine, University of Alabama at Birmingham

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85104128181&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01247-9

DO - 10.1038/s41375-021-01247-9

M3 - Letter

C2 - 33839738

AN - SCOPUS:85104128181

SN - 0887-6924

VL - 35

SP - 1823

EP - 1827

JO - Leukemia

JF - Leukemia

IS - 6

ER -

External validation of the FIRST trial’s simplified frailty score in a population-based cohort

Access to Document

Other files and links

Cite this